A BLOOD TEST THAT can predict with 90 percent accuracy if a healthy person will develop mild cognitive impairment (MCI) or Alzheimer’s disease within three years
A BLOOD TEST THAT can predict with 90 percent accuracy if a healthy person will develop mild cognitive impairment (MCI) or Alzheimer’s disease within three years has been discovered and validated by researchers at Georgetown and six other institutions.
The study team explains in the April issue of Nature Medicine (the paper was published online today) how they discovered and then validated a set of 10 lipid biomarkers in the blood that predict both conditions.
The discovery heralds the possible development of earlier treatment options for Alzheimer’s, when therapy could be more effective at slowing or even preventing onset of the disease.
“Our novel blood test offers the potential to identify people at risk for progressive cognitive decline and can change how patients, their families and treating physicians plan for and manage the disorder,” says the study’s corresponding author, Dr. Howard J. Federoff, executive vice president of health sciences at Georgetown University Medical Center.
There is currently no cure or effective treatment for Alzheimer’s disease, which, according to the World Health Organization, is expected to double every 20 years worldwide – from 35.6 million individuals in 2010 to 115.4 million by 2050.
Federoff, also a professor of neurology, explains there have been many efforts to develop drugs to slow or reverse the progression of Alzheimer’s disease, but all of them have failed. He says one reason may be the drugs were evaluated too late in the disease process.
“The preclinical state of the disease offers a window of opportunity for timely disease-modifying intervention, and biomarkers defining this asymptomatic period are critical for successful development and application of these therapeutics,” says Federoff.
‘MAJOR STEP FORWARD’
“The lipid panel was able to distinguish with 90 percent accuracy these two distinct groups – cognitively normal participants who would progress to MCI or AD within two to three years, and those who would remain normal in the near future,” says Federoff, who also serves as executive dean of the School of Medicine.
Researchers say the panel reveals changes in the breakdown of neural cell membranes resulting in 10 identifiable lipids, or metabolites, circulating in the blood. In particular, two of the 10 metabolites have strong links to the neuropathology of Alzheimer’s.
“We consider our results a major step toward the commercialization of a preclinical disease biomarker test that could be useful for large-scale screening to identify at-risk individuals,” Federoff concludes. “We’re intending to design a clinical trial where we’ll use this panel to identify people at high risk for Alzheimer’s to test a therapeutic agent that might delay or prevent the emergence of the disease.”
The Latest on: New blood test
via Google News
The Latest on: New blood test
- IIT Kharagpur researchers develop low-cost Compact Disc for blood test in rural areason January 24, 2020 at 10:06 pm
Get real-time alerts and all the news on your phone with the all-new India Today app. Download from ...
- Blood tests can predict timing of final menstrual periodon January 23, 2020 at 1:52 pm
Blood tests could replace menstrual periods as a gauge for when a women is nearing menopause, according to new research. Blood tests could replace menstrual periods as a gauge for when a women is ...
- Tests find toxic chemicals in drinking water throughout U.S. — and New Orleans ranks highon January 23, 2020 at 1:46 pm
released Wednesday. The environmental nonprofit tested water in 44 areas in 31 states and D.C. and found that New Orleans’ water system had levels of chemicals, known as per- and polyfluoroalkyl ...
- Could a new blood test predict when menopause will start?on January 23, 2020 at 1:02 pm
"New blood test can predict when women will hit the menopause two years in advance, scientists claim," reports The Sun. Researchers in the US tested the ability of a blood test for anti-mullerian ...
- Blood Culture Tests Market Size, Outlook on Key Growth Trends, Factors and Forecast to 2026on January 23, 2020 at 6:56 am
New Jersey, United States, - The report is a brilliant presentation of critical dynamics, regional growth, competition, and other important aspects of the Blood Culture Tests Market. The factual, ...
- New Blood Test Can Predict Women's Last Ever 'Time Of The Month'on January 23, 2020 at 5:05 am
Women go through menopause between the ages of 45 and 55 A new blood test can determine a woman’s last menstrual period The last menstrual period marks the end of a woman’s reproductive cycle and the ...
- Blood Culture Test Market 2020 Industry Outlook, Comprehensive Insights, Growth and Forecast 2025 – Market Research Engineon January 23, 2020 at 3:00 am
New York, January 23, 2020: The Global Blood Culture Test Market is segmented on the lines of its product, technology, application, end-user and regional. Based on product Analysis segmentation it ...
- New blood test can predict when women will hit the menopause two years in advance, scientists claimon January 22, 2020 at 4:10 pm
A BLOOD test can accurately predict when a woman will hit the menopause two years in advance, scientists claim. The new check, which measures the levels of a key hormone, can also tell how many eggs ...
- New blood test more accurately predicts the final menstrual periodon January 22, 2020 at 11:39 am
Researchers in the United States have demonstrated that a new blood test could be a superior marker of the time to menopause than bleeding patterns, or previously available tests. The results of a ...
- Blood tests can predict timing of menopause for womenon January 22, 2020 at 8:57 am
Blood tests could replace menstrual periods as a gauge for when a women is nearing menopause, according to new research published in the Endocrine Society's Journal of Clinical Endocrinology & ...
via Bing News